Century Therapeutics Inc (IPSC) — Cash Flow Reinvestment Rate
Century Therapeutics Inc (IPSC) has a Cash Flow Reinvestment Rate of 0.51x as of March 2022, reinvesting $44.04 Million (capex $4.07 Million plus investments $-39.97 Million) from operating cash flow of $86.75 Million. See IPSC FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Century Therapeutics Inc Cash Flow Reinvestment Rate (2015–2022)
Historical reinvestment intensity for Century Therapeutics Inc across 2 annual periods. For the full cash flow conversion analysis, see how efficiently does Century Therapeutics Inc generate cash.
Annual Cash Flow Reinvestment Rate for Century Therapeutics Inc (2015–2022)
Year-by-year capital reinvestment analysis for Century Therapeutics Inc. See IPSC financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 3.42x | $48.08 Million | $14.05 Million | $30.60 Million | ▲ +1114.0% |
| 2015 | 0.28x | $29.39 Million | $104.30 Million | $29.39 Million | — |